Repro Red Flags: Agency Watch

President Donald Trump has stacked his administration with anti-reproductive rights officials responsible for leading federal agencies that directly impact access to reproductive health care—including abortion, birth control, IVF, and maternal health care. 

Mobilizing against the Trump administration’s anti-repro appointments and actions.

The Center for Reproductive Rights’ tool,  Repro Red Flags: Agency Watch, shares research on these appointees, their anti-repro backgrounds, and the powers of the agencies they oversee. Importantly, it also serves as a repository of key Trump administration policies related to reproductive health.  

In a short time, the President and his extremist appointees have launched a sweeping and coordinated attack to make it harder to access sexual and reproductive health care and to undermine our fundamental human rights.

Appointees

Paula Stannard

  • Director of the Office for Civil Rights (OCR), HHS
    • Department of Health and Human Services
    • Office for Civil Rights (OCR)
Paula Stannard

Natalie Dodson

  • Senior Advisor, Office of Population Affairs
    • Department of Health and Human Services
    • Office of Population Affairs
Natalie Dodson

Andrew Guernsey

  • Senior Advisor, Immediate Office of the Secretary, HHS
    • Department of Health and Human Services
    • Office of the Secretary
Andrew Guernsey

Mark Walker

  • Ambassador-at-Large for International Religious Freedom
    • Department of State
    • The Office of International Religious Freedom
Mark Walker

Departments

Agency Watch focuses on appointments within the administration that have a broad impact on access to reproductive health care via their policies and programs, such as White House staff, as well as the Department of Health and Human Services, Department of State, and the Department of Justice.

Executive Actions

We are tracking executive actions such as Executive Orders, Presidential Memoranda, Proclamations, and Statements of Administration Policy, as well as significant agency actions, guidance, and memoranda. We also monitor ongoing rulemaking, highlighting relevant regulations and opportunities for public input.